Contents
Surgery to rebuild the shape and appearance of a breast is known as breast reconstruction. Women who have undergone breast cancer surgery frequently opt for breast reconstruction.
According to information provided by breast cancer.org, there will likely be roughly 51,400 new cases of non-invasive breast cancer and 287,857 new cases of invasive breast cancer cases in women in the United States in 2022.
The market value of breast reconstruction in 2021 was USD 2.68 billion and will reach USD 4.98 billion by 2030 at a 7.11% CAGR during 2021-2030.
Due to the rise in breast cancer operations, the accessibility of breast-restoration choices, and greater knowledge of breast reconstruction, the market for breast cancer reconstruction is probably going to grow. After breast cancer treatments such as lumpectomies, mastectomies, or other congenital disabilities, breast cancer reconstruction is performed, increasing the cosmetic appeal and boosting the confidence of women. Due to the availability of skilled plastic surgeons, advancements in technology, and safer treatments, the market for breast reconstruction has increased globally.
Market Dynamics
Drivers
The market is fostering as a result of the rising prevalence of breast cancer, the increase in breast reconstruction surgeries, and the demand for an acellular dermal matrix. According to the WHO, there will be 2.3 million new cases of breast cancer diagnosed and 685,000 deaths from the disease. Indian women are most likely to develop breast cancer, with a mortality rate of 12.7% and a rate of 25.8 per 100,000. Invasive breast cancer affects 13% of American women over their lifetimes.
Globally, the number of post-mastectomy reconstructions is rising. In 2000, ASPS reported 78,832 breast reconstruction surgeries; in 2017, 106,295 were performed.
Restraints
- One of the key factors limiting the expansion of the market is the high cost. Breast reconstruction surgery typically costs between USD 25,000 and USD 50,000, or perhaps more, for each breast and between USD 50,000 and USD 100,000.
- Mammography, Tomosynthesis, Galactography, Breast MRI, Xeromammography, Scintimammography, Elastography, Breast biopsy, and other image detection tests for early stages of breast cancer will reduce the likelihood of undergoing surgical procedures for breast reconstruction, which will significantly slow the growth of the market as a whole.
Opportunity
A skin-sparing mastectomy is becoming more commonplace throughout the world, and it is almost at the point where it will become the standard of care for breast reconstruction. Thus, It will experience exponential growth soon.
Market Segmentation
Product Insights
Based on the product, in 2022, the breast implants industry held the biggest market share. This is mostly related to growing breast cancer incidence rates and an increase in breast reconstruction surgeries. Silicone and saline implants are the two types of breast implants used in breast reconstruction and augmentation operations. Due to the widespread use of silicone implants for breast implantation operations, silicone implants held the largest market share in 2022.
End User Insights
In 2021, the hospital segment maintained the largest market position, with 45.0% of the revenue share. The growth of hospitals around the world is responsible for the segment’s domination. Globally, there has also been a rise in medical tourism. The standard of medical facilities offered by hospitals will rise as medical tourism increases.
Regional Insights
In 2021, North America had the highest revenue share of almost 40.0%. This is due to the high rate of breast cancer in this area. For instance, according to the Canadian Cancer Society, every day, 78 Canadian women are diagnosed with breast cancer, yet only 15 of them die from the disease.
Over the projection period, the Asia Pacific region will experience the quickest CAGR of 7.1%. The rise in awareness of breast reconstruction surgery and the fast rising breast cancer population are both responsible for the growth. For instance, the NCBI data revealed that there were approximately 303,600 new instances of breast cancer and 70,400 fatalities from the disease in China.
Key Players
- GC Aesthetics
- Johnson & Johnson
- SientraInc.
- Ideal Implant Incorporated
- AbbVie Inc.
- POLYTECH Health & Aesthetics GmbH
- CEREPLAS
- Arion Laboratories
- AirXpanders
- Integra Lifesciences
- PMT Corporation
- Establishment Labs S.A.
- Wanhe
- KOKEN CO. LTD.
- DPS Technology Development Ltd
- HANSBIOMED CO. LTD
- Sebbin
The market value of breast reconstruction in 2021 was USD 2.68 billion and will reach USD 4.98 billion by 2030 at a 7.11% CAGR during 2021-2030. The need for breast reconstruction therapy has grown as the prevalence of breast cancer continues to rise worldwide. Other factors driving market growth include increased healthcare spending by key economies throughout the globe and an increase in the proportion of women with genetic illnesses.
